{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:43:48Z","timestamp":1792802628302,"version":"4.5.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacig.2024.100298","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T21:34:53Z","timestamp":1720042493000},"page":"100298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosis"],"prefix":"10.1016","volume":"3","author":[{"given":"Dalan","family":"Smallwood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard F.","family":"Lockey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narasaiah","family":"Kolliputi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100298_bib1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.33160\/yam.2023.05.016","article-title":"The clinical characteristics of allergic bronchopulmonary mycosis differ among pathogenic fungi","volume":"66","author":"Harada","year":"2023","journal-title":"Yonago Acta Med"},{"key":"10.1016\/j.jacig.2024.100298_bib2","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"Asano","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3109\/13693786.2012.738312","article-title":"Global burden of allergic bronchopulmonary aspergillosis with asthma and its complication chronic pulmonary aspergillosis in adults","volume":"51","author":"Denning","year":"2013","journal-title":"Med Mycol"},{"key":"10.1016\/j.jacig.2024.100298_bib4","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/cea.12595","article-title":"Prevalence of Aspergillus sensitization and allergic bronchopulmonary aspergillosis in cystic fibrosis: systematic review and meta-analysis","volume":"45","author":"Maturu","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2024.100298_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.mycmed.2023.101392","article-title":"Allergic bronchopulmonary aspergillosis: a multidisciplinary review","volume":"33","author":"Roboubi","year":"2023","journal-title":"J Mycol Med"},{"key":"10.1016\/j.jacig.2024.100298_bib6","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1067\/mai.2002.130179","article-title":"Allergic bronchopulmonary aspergillosis","volume":"110","author":"Greenberger","year":"2002","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1398-9995.2003.00372.x","article-title":"Allergic bronchopulmonary aspergillosis without clinical asthma caused by Aspergillus niger","volume":"59","author":"Shah","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2024.100298_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3346\/jkms.2007.22.2.365","article-title":"Allergic bronchopulmonary aspergillosis coupled with broncholithiasis in a non-asthmatic patient","volume":"22","author":"Koh","year":"2007","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jacig.2024.100298_bib9","doi-asserted-by":"crossref","first-page":"18a","DOI":"10.1016\/j.chest.2022.08.016","article-title":"Case report of allergic bronchopulmonary aspergillosis in a patient without asthma or bronchiectasis","volume":"162","author":"Dong","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jacig.2024.100298_bib10","series-title":"Allergic bronchopulmonary aspergillosis. Treasure Island, FL","author":"Sisodia","year":"2024"},{"key":"10.1016\/j.jacig.2024.100298_bib11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaip.2023.01.013","article-title":"Defining the outcome markers and therapeutic role for omalizumab in treatment of allergic bronchopulmonary aspergillosis","volume":"11","author":"Greenberger","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jacig.2024.100298_bib12","first-page":"896","article-title":"Omalizumab in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis","volume":"11","author":"Jin","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib13","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1128\/CMR.12.2.310","article-title":"Aspergillus fumigatus and aspergillosis","volume":"12","author":"Latge","year":"1999","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jacig.2024.100298_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.945063","article-title":"Conventional and pathogenic Th2 cells in inflammation, tissue repair, and fibrosis","volume":"13","author":"Kokubo","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib15","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1600-065X.2008.00713.x","article-title":"Welcome to the neighborhood: epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites","volume":"226","author":"Saenz","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jacig.2024.100298_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36440-x","article-title":"IL-33, IL-25 and TSLP contribute to development of fungal-associated protease-induced innate-type airway inflammation","volume":"8","author":"Hiraishi","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jacig.2024.100298_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.155891","article-title":"Interleukin-33 (IL-33): a critical review of its biology and the mechanisms involved in its release as a potent extracellular cytokine","volume":"156","author":"Cayrol","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.jacig.2024.100298_bib18","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.cca.2019.05.023","article-title":"ST2 and the ST2\/IL-33 signalling pathway-biochemistry and pathophysiology in animal models and humans","volume":"495","author":"Pusceddu","year":"2019","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jacig.2024.100298_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41590-018-0067-5","article-title":"Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33","volume":"19","author":"Cayrol","year":"2018","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib20","doi-asserted-by":"crossref","first-page":"436","DOI":"10.3390\/jof8050436","article-title":"Serum cytokines usefulness for understanding the pathology in allergic bronchopulmonary aspergillosis and chronic pulmonary aspergillosis","volume":"8","author":"Ito","year":"2022","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jacig.2024.100298_bib21","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/rccm.202303-0580ED","article-title":"An ALARMINg Type 2 Response in cystic fibrosis-the key to understanding ABPA?","volume":"207","author":"Bojanowski","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jacig.2024.100298_bib22","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajpath.2011.03.032","article-title":"Targeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model","volume":"179","author":"Ramaprakash","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacig.2024.100298_bib23","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.4049\/jimmunol.1602186","article-title":"IL-33 Signaling regulates innate IL-17A and IL-22 production via suppression of prostaglandin E(2) during lung fungal infection","volume":"199","author":"Garth","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/cbin.11137","article-title":"Cell death: a review of the major forms of apoptosis, necrosis and autophagy","volume":"43","author":"D'Arcy","year":"2019","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.jacig.2024.100298_bib25","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jacig.2024.100298_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167378","article-title":"Apoptosis, pyroptosis, and necroptosis-oh my! The many ways a cell can die","volume":"434","author":"Ketelut-Carneiro","year":"2022","journal-title":"J Mol Biol"},{"key":"10.1016\/j.jacig.2024.100298_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aag2045","article-title":"ZBP1\/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways","volume":"1","author":"Kuriakose","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib28","article-title":"Advances in mechanism and regulation of PANoptosis: prospects in disease treatment","volume":"14","author":"Zhu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3389\/fcimb.2019.00406","article-title":"ZBP1 and TAK1: master regulators of NLRP3 inflammasome\/pyroptosis, apoptosis, and necroptosis (PAN-optosis)","volume":"9","author":"Malireddi","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jacig.2024.100298_bib30","first-page":"357","article-title":"PANoptosis-like cell death in ischemia\/reperfusion injury of retinal neurons","volume":"18","author":"Yan","year":"2023","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.jacig.2024.100298_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3390\/jof7030231","article-title":"Fungal-induced programmed cell death","volume":"7","author":"Williams","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jacig.2024.100298_bib32","doi-asserted-by":"crossref","first-page":"18276","DOI":"10.1074\/jbc.RA120.015924","article-title":"ZBP1 promotes fungi-induced inflammasome activation and pyroptosis, apoptosis, and necroptosis (PANoptosis)","volume":"295","author":"Banoth","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jacig.2024.100298_bib33","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.it.2023.01.001","article-title":"ADAR1 and ZBP1 in innate immunity, cell death, and disease","volume":"44","author":"Karki","year":"2023","journal-title":"Trends Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib34","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fcimb.2020.00238","article-title":"The PANoptosome: a deadly protein complex driving pyroptosis, apoptosis, and necroptosis (PANoptosis)","volume":"10","author":"Samir","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jacig.2024.100298_bib35","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1016\/j.bcp.2007.12.020","article-title":"A cyclopentanediol analogue selectively suppresses the conserved innate immunity pathways, Drosophila IMD and TNF-alpha pathways","volume":"75","author":"Sekiya","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacig.2024.100298_bib36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/s41564-018-0298-0","article-title":"Fungal ligands released by innate immune effectors promote inflammasome activation during Aspergillus fumigatus infection","volume":"4","author":"Briard","year":"2019","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.jacig.2024.100298_bib37","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5538612","article-title":"Aspergillus fumigatus influences gasdermin-D-dependent pyroptosis of the lung via regulating Toll-like receptor\u00a02-mediated regulatory T cell differentiation","volume":"2021","author":"Yan","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jacig.2024.100298_bib38","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846065","article-title":"The fungal ligand chitin directly binds TLR2 and triggers inflammation dependent on oligomer size","volume":"19","author":"Fuchs","year":"2018","journal-title":"EMBO Rep"},{"key":"10.1016\/j.jacig.2024.100298_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.riam.2010.10.003","article-title":"What makes Aspergillus fumigatus a successful pathogen? Genes and molecules involved in invasive aspergillosis","volume":"27","author":"Abad","year":"2010","journal-title":"Rev Iberoam Micol"},{"key":"10.1016\/j.jacig.2024.100298_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01755-18","article-title":"The multifunctional fungal ergosterol","volume":"9","author":"Rodrigues","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.jacig.2024.100298_bib41","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1038\/s41418-019-0323-8","article-title":"Dectin-1-induced RIPK1 and RIPK3 activation protects host against Candida albicans infection","volume":"26","author":"Cao","year":"2019","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.jacig.2024.100298_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/febs.14738","article-title":"Necroptosis directly induces the release of full-length biologically active IL-33 in\u00a0vitro and in an inflammatory disease model","volume":"286","author":"Shlomovitz","year":"2019","journal-title":"FEBS J"},{"key":"10.1016\/j.jacig.2024.100298_bib43","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.chom.2015.01.006","article-title":"Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection","volume":"17","author":"Karki","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jacig.2024.100298_bib44","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ajpath.2019.10.012","article-title":"Necroptosis in the pathophysiology of disease","volume":"190","author":"Khoury","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jacig.2024.100298_bib45","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s13045-022-01392-3","article-title":"Targeting cell death pathways for cancer therapy: recent developments in necroptosis, pyroptosis, ferroptosis, and cuproptosis research","volume":"15","author":"Tong","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.jacig.2024.100298_bib46","doi-asserted-by":"crossref","first-page":"22219","DOI":"10.18632\/oncotarget.7924","article-title":"Key roles of necroptotic factors in promoting tumor growth","volume":"7","author":"Liu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jacig.2024.100298_bib47","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cell.2011.11.031","article-title":"Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase","volume":"148","author":"Sun","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.jacig.2024.100298_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat2738","article-title":"Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis","volume":"3","author":"Rathkey","year":"2018","journal-title":"Sci Immunol"},{"key":"10.1016\/j.jacig.2024.100298_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112648","article-title":"Necrosulfonamide reverses pyroptosis-induced inhibition of proliferation and differentiation of osteoblasts through the NLRP3\/caspase-1\/GSDMD pathway","volume":"405","author":"Zhang","year":"2021","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.jacig.2024.100298_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115338","article-title":"Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis","volume":"206","author":"Yang","year":"2022","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jacig.2024.100298_bib51","first-page":"2683","article-title":"Necrosulfonamide (NSA) protects intervertebral disc degeneration via necroptosis and apoptosis inhibition","volume":"24","author":"Zhang","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.jacig.2024.100298_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105297","article-title":"Necrostatin-1 and necroptosis inhibition: pathophysiology and therapeutic implications","volume":"163","author":"Cao","year":"2021","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacig.2024.100298_bib53","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20191644","article-title":"Innate immune priming in the absence of TAK1 drives RIPK1 kinase activity-independent pyroptosis, apoptosis, necroptosis, and inflammatory disease","volume":"217","author":"Malireddi","year":"2020","journal-title":"J Exp Med"},{"key":"10.1016\/j.jacig.2024.100298_bib54","doi-asserted-by":"crossref","DOI":"10.1177\/20406223211047003","article-title":"Review of current and future therapeutics in ABPA","volume":"12","author":"Lewington-Gower","year":"2021","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.jacig.2024.100298_bib55","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/medicina58010053","article-title":"The use of targeted monoclonal antibodies in the treatment of ABPA-a case series","volume":"58","author":"O'Reilly","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.jacig.2024.100298_bib56","doi-asserted-by":"crossref","first-page":"9825","DOI":"10.1038\/s41598-023-36642-y","article-title":"Tozorakimab (MEDI3506): an anti-IL-33 antibody that inhibits IL-33 signalling via ST2 and RAGE\/EGFR to reduce inflammation and epithelial dysfunction","volume":"13","author":"England","year":"2023","journal-title":"Sci Rep"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324000948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:48:52Z","timestamp":1731347332000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324000948"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2772829324000948"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100298","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PANoptosis opens new treatment options for allergic bronchopulmonary aspergillosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100298","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100298"}}